Down-regulation of transforming growth factor-α by tamoxifen in human breast cancer
✍ Scribed by Shinzaburo Noguchi; Kazuyoshi Motomura; Hideo Inaji; Shingi Imaoka; Hiroki Koyama
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 548 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background. Influence of tamoxifen treatment on estrogen receptor (ER) and progesterone receptor (PR) levels in human breast cancer has not been fully elucidated in vivo. This problem was studied in 20 postmenopausal patients with ER-positive and PR-positive primary breast cancer. Each patient unde
Basic fibroblast growth factor (bFGF) and transforming growth factor beta 1 (TGFP1) are potential autocrine growth regulators of the prostatic stroma, and therefore may play a role in the development of benign prostatic hyperplasia (BPH). We reported [Story et al.: Prostate 22:183-197, 19931 that TG
Transforming growth factor-s (TGFs) play a prominent role in tumour growth and metastasis by enhancing angiogenesis and suppressing immune surveillance. Despite the increased interest in the effect of TGFs on tumour progression, little is known about the importance of TGF3 and its receptor CD105